PL358136A1 - Proces otrzymywania sterylnej maści zawierającej acyklovir - Google Patents
Proces otrzymywania sterylnej maści zawierającej acyklovirInfo
- Publication number
- PL358136A1 PL358136A1 PL01358136A PL35813601A PL358136A1 PL 358136 A1 PL358136 A1 PL 358136A1 PL 01358136 A PL01358136 A PL 01358136A PL 35813601 A PL35813601 A PL 35813601A PL 358136 A1 PL358136 A1 PL 358136A1
- Authority
- PL
- Poland
- Prior art keywords
- sterile
- ointment
- acyclovir
- acid addition
- addition salt
- Prior art date
Links
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004150 aciclovir Drugs 0.000 title abstract 4
- 239000002674 ointment Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000000969 carrier Substances 0.000 abstract 2
- 229940057995 liquid paraffin Drugs 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003885 eye ointment Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000007789 sealing Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 229940099259 vaseline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0002266A HU226058B1 (en) | 2000-06-14 | 2000-06-14 | Process for producing sterile acyclovir cream |
| PCT/HU2001/000069 WO2001095878A1 (en) | 2000-06-14 | 2001-06-13 | Process for the preparation of a sterile ointment containing acyclovir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL358136A1 true PL358136A1 (pl) | 2004-08-09 |
Family
ID=89978395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01358136A PL358136A1 (pl) | 2000-06-14 | 2001-06-13 | Proces otrzymywania sterylnej maści zawierającej acyklovir |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1289495B1 (pl) |
| JP (1) | JP2004503485A (pl) |
| AT (1) | ATE277597T1 (pl) |
| AU (1) | AU2001269346A1 (pl) |
| BG (1) | BG107386A (pl) |
| CZ (1) | CZ20023731A3 (pl) |
| DE (1) | DE60106024D1 (pl) |
| EA (1) | EA200201188A1 (pl) |
| HR (1) | HRP20020857A2 (pl) |
| HU (1) | HU226058B1 (pl) |
| PL (1) | PL358136A1 (pl) |
| SK (1) | SK16772002A3 (pl) |
| UA (1) | UA73769C2 (pl) |
| WO (1) | WO2001095878A1 (pl) |
| YU (1) | YU86302A (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0312817A (pt) * | 2002-07-23 | 2005-04-19 | Novartis Ag | Composição de pomada oftálmica compreendendo uma droga, uma base de pomada e um agente solubilizante/dispersante |
| CN115463102B (zh) * | 2022-09-26 | 2023-11-24 | 湖北科益药业股份有限公司 | 一种阿昔洛韦片剂及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300296A (en) * | 1989-11-06 | 1994-04-05 | Frank J. Holly | Antimicrobial agent for opthalmic formulations |
| CZ284920B6 (cs) * | 1996-02-14 | 1999-04-14 | Vladimír Prof. Mudr. Drsc. Vonka | Preparáty pro léčbu rekurentního herpesu založené na potenciaci účinků syntetických virostatik kofeinem |
| ITMI981528A1 (it) * | 1998-07-03 | 2000-01-03 | Recordati Ind Chimica E Farma | Formulazioni topiche di aciclovir |
-
2000
- 2000-06-14 HU HU0002266A patent/HU226058B1/hu unknown
-
2001
- 2001-06-13 AU AU2001269346A patent/AU2001269346A1/en not_active Abandoned
- 2001-06-13 EA EA200201188A patent/EA200201188A1/ru unknown
- 2001-06-13 UA UA20021210046A patent/UA73769C2/uk unknown
- 2001-06-13 HR HRP20020857 patent/HRP20020857A2/hr not_active Application Discontinuation
- 2001-06-13 JP JP2002510057A patent/JP2004503485A/ja active Pending
- 2001-06-13 CZ CZ20023731A patent/CZ20023731A3/cs unknown
- 2001-06-13 PL PL01358136A patent/PL358136A1/pl unknown
- 2001-06-13 SK SK1677-2002A patent/SK16772002A3/sk unknown
- 2001-06-13 YU YU86302A patent/YU86302A/sh unknown
- 2001-06-13 EP EP01947701A patent/EP1289495B1/en not_active Expired - Lifetime
- 2001-06-13 DE DE60106024T patent/DE60106024D1/de not_active Expired - Lifetime
- 2001-06-13 WO PCT/HU2001/000069 patent/WO2001095878A1/en not_active Ceased
- 2001-06-13 AT AT01947701T patent/ATE277597T1/de not_active IP Right Cessation
-
2002
- 2002-12-13 BG BG107386A patent/BG107386A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0002266A3 (en) | 2005-01-28 |
| WO2001095878A1 (en) | 2001-12-20 |
| ATE277597T1 (de) | 2004-10-15 |
| CZ20023731A3 (cs) | 2003-04-16 |
| HU0002266D0 (en) | 2000-08-28 |
| JP2004503485A (ja) | 2004-02-05 |
| HRP20020857A2 (en) | 2004-12-31 |
| AU2001269346A1 (en) | 2001-12-24 |
| EP1289495A1 (en) | 2003-03-12 |
| BG107386A (bg) | 2003-11-28 |
| EP1289495B1 (en) | 2004-09-29 |
| YU86302A (sh) | 2005-11-28 |
| UA73769C2 (pl) | 2005-09-15 |
| SK16772002A3 (sk) | 2003-04-01 |
| HUP0002266A2 (hu) | 2002-05-29 |
| EA200201188A1 (ru) | 2003-06-26 |
| DE60106024D1 (de) | 2004-11-04 |
| HU226058B1 (en) | 2008-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002080883A3 (en) | Method and composition for solubilising a biologically active compound with low water solubility | |
| CA2561167A1 (en) | Composition of solifenacin or salt thereof for use in solid formulation | |
| WO2003007868A8 (en) | Storage of liquid compositions | |
| PT85591A (en) | Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa | |
| HU9400430D0 (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
| EP1813274A4 (en) | MEDICAL COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR STABILIZING A DIHYDROPYRIDINE COMPOUND IN A MEDICAL COMPOSITION | |
| MXPA06000226A (es) | Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo[3.3..0]-octano-3-carboxilico. | |
| CA2477557A1 (en) | Stabilized albumin preparations | |
| AU7827601A (en) | Anthelmintic composition | |
| PL358136A1 (pl) | Proces otrzymywania sterylnej maści zawierającej acyklovir | |
| PL308838A1 (en) | Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations | |
| CN107496366B (zh) | 一种美洛西林钠舒巴坦钠化合物的药物组合物 | |
| EP0242653B1 (en) | Tpa-containing medical composition and use thereof | |
| AU1039400A (en) | Opioid analgesic | |
| US6479627B1 (en) | Aqueous preparation of lactoferrin having improved stability | |
| GB2358398B8 (en) | Steroid compounds, a method for preparation thereof, pharmaceutical compositions containing the same and use thereof | |
| CA2534259A1 (en) | Glycyrrhizin high-concentration preparation | |
| CN108498467B (zh) | 注射用重组人生长激素无菌粉末及其制备方法 | |
| EP0362277A1 (en) | Preservative free ophthalmic ointments | |
| WO2003099256A3 (de) | FLIESSFÄHIGE, PULVERFÖRMIGE α-LIPONSÄURE(-DERIVATE) ENTHALTENDE ZUSAMMENSETZUNG | |
| US20080287543A1 (en) | Pharmaceutical composition comprising 5-methyl-2 (2'-chloro-6'-fluoroanillino) phen ylacetic acid | |
| US20020072602A1 (en) | Micronized mirtazapine | |
| BG106114A (en) | Mastic and method for the preparation of a pharmaceutical form of paclitaxel | |
| TH14172A (th) | สารละลายเมสนาซึ่งฉีดได้ |